NEUROBO PHARMACEUTICALS INC. - 15 min. - Technical analysis published on 07/21/2021 (GMT)
- 197
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 15 min.
- - Analysis generated on
- Status : INVALID
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
67%
6%
28%
My opinion
Bullish above 3.39 USD
My targets
4.24 USD (+6.88%)
4.46 USD (+12.27%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on NEUROBO PHARMACEUTICALS INC. as long as the price remains well above 3.39 USD. The buyers' bullish objective is set at 4.24 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 4.46 USD. If there is any crossing, the next objective would be the resistance located at 5.13 USD. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The NEUROBO PHARMACEUTICALS INC. rating is 3.97 USD. On the day, this instrument gained +40.78% with the lowest point at 3.78 USD and the highest point at 5.62 USD. The deviation from the price is +5.03% for the low point and -29.36% for the high point.3.78
5.62
3.97
Here is a more detailed summary of the historical variations registered by NEUROBO PHARMACEUTICALS INC.:
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 15 min. chart of NEUROBO PHARMACEUTICALS INC. indicates that the overall trend is strongly bullish. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner is currently detecting several bearish signals that could impact this trend:
Bearish trend reversal : Moving Average 20
Type : Bearish
Timeframe : 15 minutes
Bearish price crossover with adaptative moving average 100
Type : Bearish
Timeframe : 15 minutes
The technical indicators are bullish. There is still some doubt about the price increase.
But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : 15 minutes
Momentum indicator is back under 0
Type : Bearish
Timeframe : 15 minutes
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 3.11 | 3.46 | 3.94 | 3.97 | 4.63 | 5.13 | 5.70 |
| Change (%) | -21.66% | -12.85% | -0.76% | - | +16.62% | +29.22% | +43.58% |
| Change | -0.86 | -0.51 | -0.03 | - | +0.66 | +1.16 | +1.73 |
| Level | Minor | Minor | Intermediate | - | Intermediate | Intermediate | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.45 | 2.62 | 3.29 | 4.46 | 5.13 | 6.30 | 6.97 |
| Camarilla | 3.46 | 3.63 | 3.80 | 3.97 | 4.14 | 4.31 | 4.48 |
| Woodie | 1.21 | 2.50 | 3.05 | 4.34 | 4.89 | 6.18 | 6.73 |
| Fibonacci | 2.62 | 3.32 | 3.75 | 4.46 | 5.16 | 5.59 | 6.30 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 2.19 | 2.44 | 2.59 | 2.84 | 2.99 | 3.24 | 3.39 |
| Camarilla | 2.62 | 2.66 | 2.69 | 2.73 | 2.77 | 2.80 | 2.84 |
| Woodie | 2.13 | 2.42 | 2.53 | 2.82 | 2.93 | 3.22 | 3.33 |
| Fibonacci | 2.44 | 2.60 | 2.69 | 2.84 | 3.00 | 3.09 | 3.24 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -1.82 | 0.50 | 1.92 | 4.24 | 5.66 | 7.98 | 9.40 |
| Camarilla | 2.30 | 2.64 | 2.99 | 3.33 | 3.67 | 4.02 | 4.36 |
| Woodie | -2.28 | 0.28 | 1.46 | 4.02 | 5.20 | 7.76 | 8.94 |
| Fibonacci | 0.50 | 1.93 | 2.82 | 4.24 | 5.67 | 6.56 | 7.98 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 76.84 | |
| MACD (12,26,9): | 0.3800 | |
| Directional Movement: | 35.26 | |
| AROON (14): | 42.86 | |
| DEMA (21): | 4.04 | |
| Parabolic SAR (0,02-0,02-0,2): | 3.23 | |
| Elder Ray (13): | 0.35 | |
| Super Trend (3,10): | 3.62 | |
| Zig ZAG (10): | 4.19 | |
| VORTEX (21): | 1.0700 | |
| Stochastique (14,3,5): | 82.24 | |
| TEMA (21): | 4.40 | |
| Williams %R (14): | -18.44 | |
| Chande Momentum Oscillator (20): | 1.40 | |
| Repulse (5,40,3): | -3.6700 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 1.4800 | |
| Courbe Coppock: | 98.47 |
| MA7: | 3.00 | |
| MA20: | 3.09 | |
| MA50: | 3.07 | |
| MA100: | 3.55 | |
| MAexp7: | 4.04 | |
| MAexp20: | 3.52 | |
| MAexp50: | 3.14 | |
| MAexp100: | 3.01 | |
| Price / MA7: | +32.33% | |
| Price / MA20: | +28.48% | |
| Price / MA50: | +29.32% | |
| Price / MA100: | +11.83% | |
| Price / MAexp7: | -1.73% | |
| Price / MAexp20: | +12.78% | |
| Price / MAexp50: | +26.43% | |
| Price / MAexp100: | +31.89% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis NEUROBO PHARMACEUTICALS INC. - 15 min.